Intangible Assets, Net (Excluding Goodwill) in USD of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Intangible Assets, Net (Excluding Goodwill) history and change rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Intangible Assets, Net (Excluding Goodwill) for the quarter ending 30 Jun 2023 was $24,935,000.000, a 2.46% decline year-over-year.

Intangible Assets, Net (Excluding Goodwill), Quarterly (USD)

Intangible Assets, Net (Excluding Goodwill), YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Intangible Assets, Net (Excluding Goodwill) (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$24,935,000	-$630,000	-2.5%	30 Jun 2023	10-Q	09 Aug 2023
Q1 2023	$25,093,000			31 Mar 2023	10-Q	11 May 2023
Q4 2022	$25,250,000	-$10,712,000	-29.8%	31 Dec 2022	10-Q	09 Aug 2023
Q2 2022	$25,565,000			30 Jun 2022	6-K	29 Aug 2022
Q4 2021	$35,962,000	-$867,000	-2.4%	31 Dec 2021	10-K	30 Mar 2023
Q4 2020	$36,829,000			31 Dec 2020	20-F	26 Apr 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.